<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Multiple intracellular signaling pathways, such as Wnt/Î²-catenin signaling, epidermal growth factor receptor/Ras signaling, and p53 signaling are frequently dysregulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent evidence also points to the involvement of signaling pathways in the developmental process, including Notch signaling, Hedgehog signaling, and Hippo signaling </plain></SENT>
<SENT sid="2" pm="."><plain>Dysregulation of these signaling pathways contribute to the acquisition of malignant phenotypes, including unchecked cell cycle progression, evasion of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, induction of genetic instability, and enhanced invasiveness and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Understanding their relative importance and crosstalk will provide a rational basis for anticancer drug development </plain></SENT>
</text></document>